RU94006580A - Adaptogen trecresan in medicine - Google Patents

Adaptogen trecresan in medicine

Info

Publication number
RU94006580A
RU94006580A RU94006580/14A RU94006580A RU94006580A RU 94006580 A RU94006580 A RU 94006580A RU 94006580/14 A RU94006580/14 A RU 94006580/14A RU 94006580 A RU94006580 A RU 94006580A RU 94006580 A RU94006580 A RU 94006580A
Authority
RU
Russia
Prior art keywords
adaptogen
medicine
hydroxyethyl
tris
trecresan
Prior art date
Application number
RU94006580/14A
Other languages
Russian (ru)
Other versions
RU2063749C1 (en
Inventor
М.Г. Воронков
Е.Я. Каплан
В.М. Дьяков
Ю.В. Буров
Н.В. Семенова
Original Assignee
М.Г. Воронков
Е.Я. Каплан
В.М. Дьяков
Ю.В. Буров
Н.В. Семенова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by М.Г. Воронков, Е.Я. Каплан, В.М. Дьяков, Ю.В. Буров, Н.В. Семенова filed Critical М.Г. Воронков
Priority to RU94006580/14A priority Critical patent/RU2063749C1/en
Application granted granted Critical
Publication of RU2063749C1 publication Critical patent/RU2063749C1/en
Publication of RU94006580A publication Critical patent/RU94006580A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: medicine, zooveterinary science. SUBSTANCE: invention proposes to use tris-(2-hydroxyethyl)-ammonium ortho-cresoxy-acetate as adaptogen agent. Proposed agent promotes homeostasis retention under effect of unfavorable factors on human organism (physical, chemical and biological factors). Proposed tris-(2-hydroxyethyl)-ammonium ortho-cresoxy-acetate (trecresan) is adaptogen of broad spectrum action. EFFECT: agent indicated above, enhanced effectiveness.

Claims (1)

Изобретение относится к области медицины, зооветеринарии и касается применения трис-(2-оксиэтил)-аммоний орто-крезоксиацетата (трекрезана) в медицинской и зооветеринарной практике в качестве адаптогена широкого спектра действия. Задача изобретения создание и применение лекарственного средства, обладающего адаптогенным действием, в частности, способствующим сохранению гомеостаза при воздействии на организм человека неблагоприятных факторов физической, химической и биологической природы. Предлагается использовать трис-(2-оксиэтил)-аммоний орто-крезоксиацетат в качестве адаптогена.The invention relates to the field of medicine, veterinary medicine and the use of tris- (2-hydroxyethyl) -ammonium ortho-cresoxyacetate (trekrezan) in medical and veterinary practice as an adaptogen of a wide spectrum of action. The objective of the invention is the creation and use of a medicinal product with adaptogenic effects, in particular, contributing to the preservation of homeostasis when exposed to the human body by adverse factors of a physical, chemical and biological nature. It is proposed to use tris- (2-hydroxyethyl) -ammonium ortho-cresoxyacetate as an adaptogen.
RU94006580/14A 1994-02-24 1994-02-24 Medicinal agent showing adaptogenic action RU2063749C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94006580/14A RU2063749C1 (en) 1994-02-24 1994-02-24 Medicinal agent showing adaptogenic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94006580/14A RU2063749C1 (en) 1994-02-24 1994-02-24 Medicinal agent showing adaptogenic action

Publications (2)

Publication Number Publication Date
RU2063749C1 RU2063749C1 (en) 1996-07-20
RU94006580A true RU94006580A (en) 1997-03-20

Family

ID=20152853

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94006580/14A RU2063749C1 (en) 1994-02-24 1994-02-24 Medicinal agent showing adaptogenic action

Country Status (1)

Country Link
RU (1) RU2063749C1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2704354C1 (en) * 2019-07-10 2019-10-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр реабилитации и курортологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ РК" Минздрава России) Method for preventing development of corneal opacity in case of mechanical injuries

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1714674A1 (en) * 2005-04-21 2006-10-25 Desol BV Method for improving the fertility of animals
RU2444357C1 (en) * 2010-12-22 2012-03-10 Максуд Мухамеджанович Расулов Agent to decrease cholesterol esterase activity
RU2445087C1 (en) * 2010-12-22 2012-03-20 Максуд Мухамеджанович Расулов Agent modulating acid phospholipase a1 activity
RU2460524C1 (en) * 2011-04-12 2012-09-10 Максуд Мухамеджанович Расулов Agent stimulating pgc-1a coactivator gene expression
RU2734728C1 (en) * 2019-11-26 2020-10-22 Государственное автономное образовательное учреждение Астраханской области высшего образования "Астраханский государственный архитектурно-строительный университет" ГАОУ АО ВО "АГАСУ" Using protatran 4-chloro-2-methylphenoxyacetate (chlorine crezacin) in 0_9 % sodium chloride solution to stimulate static and dynamic operability
RU2734899C1 (en) * 2019-11-26 2020-10-26 Государственное автономное образовательное учреждение Астраханской области высшего образования "Астраханский государственный архитектурно-строительный университет" ГАОУ АО ВО "АГАСУ" Use of an aqueous solution of protran 4-chloro-2-methylphenoxyacetate (chlorine crezacin) to stimulate static and dynamic operability
RU2762552C2 (en) * 2020-10-05 2021-12-21 Общество с ограниченной ответственностью "Гротекс" (ООО "Гротекс") Pharmaceutical composition of oxy-ethylammonium methylphenoxyacetate
RU2769519C1 (en) * 2021-06-02 2022-04-01 Государственное автономное образовательное учреждение Астраханской области высшего образования "Астраханский государственный архитектурно-строительный университет" ГАОУ АО ВО "АГАСУ" Tool that improves the coordination of the musculoskeletal system of a person with 2nd degree obesity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2704354C1 (en) * 2019-07-10 2019-10-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр реабилитации и курортологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ РК" Минздрава России) Method for preventing development of corneal opacity in case of mechanical injuries

Also Published As

Publication number Publication date
RU2063749C1 (en) 1996-07-20

Similar Documents

Publication Publication Date Title
ATE30575T1 (en) STABILIZED ACTIVATED OXYGEN AND PHARMACEUTICALS CONTAINING SUCH STABILIZED ACTIVATED OXYGEN.
MX9605940A (en) Bio-aromatic compounds carrying an adamantyl group in ortho, pharmaceutical and cosmetic compositions containing them and utilization.
SE9401406L (en) Pharmaceutical products for the cure of tumor diseases as well as a method for the preparation thereof
DE69426669D1 (en) VETERINARY MEDICINAL PRODUCT CONTAINING A PROTON PUMP INHIBITOR
RU94022017A (en) Method of treatment of acne or bread pseudofolliculitis, method of composition preparing, use of enzyme ornitine decarboxylase inhibitor for acne and bread folliculitis treatment
DE69116380D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING EXTENDED COAGLING TIME
RU94006580A (en) Adaptogen trecresan in medicine
FR2756561B1 (en) HETEROARYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND USES
ATE69550T1 (en) SALICYLIC ACID AGENT AGAINST SCALPING SKIN DISEASES.
ATE289611T1 (en) PEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
FR2358893A1 (en) ANTIMICROBIAL COMPOSITION CONTAINING 1-IMIDAZOLYL-BUTANE-2-ONES OR -BUTANE-2-OLS HALOGENES
HUP9903688A2 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating autism
SULZBERGER et al. DEVELOPMENT AND USE OF BAL: A Review, with Particular Reference to Arsenical Dermatitis
RU2196590C1 (en) Agent carbon-mercury hydrosulfate complex and method of treatment of infectious inflammatory sicknesses
SU607571A1 (en) Composition for treating persons suffering from fungous diseases
ATE66815T1 (en) MEDICATION CONTAINING AN ORGAN EXTRACT PRODUCED FROM PEYER'S PLAQUES FOR THE TREATMENT OF DIABETES MELLITUS AND PANCREATITIS.
Weaver Burn wounds: their treatment
RU2123364C1 (en) Method for treatment of inflammatory processes and device intended for its realization
Kas' ko Main results of the activities of the Chair of Dermatology and Venereal Diseases of the Chernovitz Medical Institute and its contribution to the organization and development of dermatology and venereology in Bukovina
Brain A Classification of Nerve Injuries
FR2385721A1 (en) CYCLOPROPYL-6 DIHYDRO-1,3 METHYL-1 PHENYL-5 OXO-2 2 H-THIENO (2,3-E) DIAZEPINE, ITS PREPARATION PROCESS AND ITS THERAPEUTIC APPLICATION
RU94019564A (en) Method of gastroenteric diseases treatment
JP2006089450A (en) Fulvic acid
WI et al. 350 SEPT. 19, 1942 CORRESPONDENCE MEDICAL JOURNAL
Baumann SCIENCE AND MEDICINE WITH SPECIAL REFERENCE TO THE TREATMENT OF SYPHILIS AND GONORRHEA

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20050225